Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nancy E KemenyRobert J Mayer

Abstract

Hepatic metastases derive most of their blood supply from the hepatic artery; therefore, for patients with hepatic metastases from colorectal cancer, hepatic arterial infusion (HAI) of chemotherapy may improve outcome. In a multi-institutional trial, 135 patients were randomly assigned to receive HAI versus systemic bolus fluorouracil and leucovorin. The primary end point was survival; secondary end points were response, recurrence, toxicity, quality of life, cost, and the influence of molecular markers. Overall survival was significantly longer for HAI versus systemic treatment (median, 24.4 v 20 months; P = .0034), as were response rates (47% and 24%; P = .012) and time to hepatic progression (THP; 9.8 v 7.3 months; P = .034). Time to extrahepatic progression (7.7 v 14.8 months; P = .029) was significantly shorter in the HAI group. Quality-of-life measurements showed improved physical functioning in the HAI group at the 3- and 6-month follow-up assessments. Toxicity included grade > or = 3 neutropenia (2% and 45%; P < .01), stomatitis (0% and 24%; P < .01), and bilirubin elevation (18.6% and 0; P < .01) in the HAI and systemic treatment groups, respectively. A greater proportion of men versus women receiving HAI experienced b...Continue Reading

References

Jul 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P RougierD Gallot
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W GrafR Bergström
Aug 1, 1991·Journal of Clinical Pathology·D G Altman
Jan 1, 1991·Social Science & Medicine·C D Sherbourne, A L Stewart
Nov 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L D WagmanD U Riihimaki
Mar 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Y BedikianG P Bodey
Nov 4, 1994·Science·S W LoweT Jacks
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R K PortenoyL Norton
Oct 1, 1993·Health Economics·R D HaysR M Mazel
Oct 1, 1996·Genome Research·C A HeidP M Williams
Oct 1, 1996·Genome Research·U E GibsonP M Williams
Jan 15, 1997·Statistics in Medicine·J W Hogan, N M Laird
May 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N KemenyP Paty
Aug 4, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H H BackusG J Peters
Dec 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y ShirotaH J Lenz
Feb 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mithat GonenNancy Kemeny
Feb 8, 2003·Lancet·David J KerrUNKNOWN European Organisation for Research and Treatment of Cancer colorectal cancer study group
Jun 1, 1953·Thorax·L CUDKOWICZ, J B ARMSTRONG
Dec 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard M GoldbergSteven R Alberts
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel GrotheyHans-Joachim Schmoll
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jan 22, 2005·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy KemenyYuman Fong

❮ Previous
Next ❯

Citations

Nov 10, 2007·Der Radiologe·A LubienskiT Helmberger
Feb 18, 2009·Cancer Chemotherapy and Pharmacology·Archie N TseNancy Kemeny
Mar 6, 2010·International Journal of Colorectal Disease·Shin FujitaMasayuki Ohue
Oct 19, 2006·Journal of Gastroenterology·Yasuhiro InoueMasato Kusunoki
Oct 12, 2012·Clinical & Experimental Metastasis·Harold J WaneboNancey E Kemeny
Jul 9, 2011·Investigational New Drugs·Paul ZarogoulidisKostantinos Zarogoulidis
Oct 6, 2010·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Yunlong CuiQiang Li
Aug 15, 2006·Current Treatment Options in Oncology·Smitha Patiyil, Steven R Alberts
Aug 15, 2006·Current Treatment Options in Oncology·Cletus A Arciero, Elin R Sigurdson
Mar 17, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Paula Manchon WalshUNKNOWN Colorectal Cancer OncoGuia Group
Apr 13, 2007·The New England Journal of Medicine·Pierre-Alain ClavienRolf Graf
Jun 4, 2008·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Frederic GagnadouxEtienne Lemarie
Apr 21, 2010·The Cancer Journal·Margaret K Callahan, Nancy E Kemeny
May 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marwan G FakihRobert B Diasio
Jul 16, 2008·International Seminars in Surgical Oncology : ISSO·Panagiotis SamarasBernhard C Pestalozzi
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy E KemenyMichael D'Angelica
Jan 20, 2007·Annals of Surgical Oncology·Kuniya TanakaShinji Togo
May 24, 2012·International Journal of Nanomedicine·Paul ZarogoulidisKonstantinos Zarogoulidis
Jan 10, 2012·World Journal of Gastroenterology : WJG·Chen-Chen Wang, Jin Li
Jul 28, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Bohuslav Melichar
May 24, 2011·Radiology·Robert J LewandowskiRiad Salem
May 22, 2013·International Journal of Hepatology·Yi-Hsin LiangZhong-Zhe Lin
Jun 22, 2014·Current Treatment Options in Oncology·Michael A Choti
Jun 18, 2011·Abdominal Imaging·Thierry de Baere, Frederic Deschamps

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.